Health Canada is warning about a recall of EpiPen and EpiPen Jr. auto-injectors.
The government’s health watchdog said Monday the devices, made by Pfizer Canada, may contain a defective part that could cause the auto-injector to fail to activate, or may be more difficult to activate.
The affected devices have the lot numbers 5GU763 and 5GR765 and May and March 2017 expiry dates.
There have been two confirmed international cases of devices that failed to operate, but so far no cases have been reported in Canada.
“Failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline (epinephrine), resulting in the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life-threatening,” Health Canada said in a statement.
If you have one of these devices, you are being urged to return it to your pharmacy and get a replacement. In a statement, Health Canada advises anyone who suffers an allergic reaction before returning their device to use it as directed and then seek medical attention.